University of Munster
Research in breast cancer provides new insights
Published in Women's Health Law Weekly, April 9th, 2006
Study 1: Amplifications of the epidermal growth factor receptor (EGFR) gene were associated with progression of phyllodes tumor of the breast.
According to a study from Germany, "Phyllodes tumors of the breast are rare biphasic tumors with the potential for invasion and metastatic spread. An important role of the EGFR in phyllodes tumors has been proposed. However, detailed pathogenetic mechanisms remained unclear."
"We investigated 58 phyllodes tumors of the breast (40 benign, 10 borderline and 8 malignant) by means of EGFR fluorescence in situ...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Law Weekly
More Articles from Women's Health Law Weekly
- Adeza
Adeza achieves 14th consecutive quarter of profitability - Biomarker Technologies, LLC
Accuracy of blood test for breast cancer to be subject of clinical study by Biomarker - Chelsea & Westminster Hospital, London
AIDS-related malignancy epidemiology and outcome has changed in the era of HAART - Dana-Farber Cancer Institute, Boston
Ovarian cancer patients treated by gynecologic oncologists had better outcomes - Hospital General Gregorio Maranon, Murcia
ABC, 3TC, and ZDV is reasonable for HAART-naive patients when other regimens are ill-advised - University of Michigan
Women's high heart-surgery death rate may be due to infection - More from this issue of Women's Health Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
